Pfizer/ISA- Cardiac Transthyretin Amyloid (ATTR) Fellowship – Request for Proposals

Well-being, Health and Biomedical Discovery


Academic Unit: Inquire within your unit

Memorial Deadline: Wednesday 18th, August 2021

External Deadline: Monday 23rd, August 2021


The International Society of Amyloidosis (ISA) and Pfizer are collaborating to offer a new competitive grant opportunity focused on supporting fellowships in Cardiac Transthyretin Amyloid (ATTR).

The mission of the International Society of Amyloidosis (ISA) is to promote research, education, clinical studies (including diagnosis and treatment), conferences and symposia on all aspects of amyloidosis worldwide.

The mission of Pfizer Global Medical Grants is to accelerate the translation of science into quality patient care through independent grants, partnerships, and collaborations. Pfizer Global Medical Grants supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

This Request for Proposals (RFP) is being issued by both organizations. An expert review panel will be selected by ISA and will make decisions on which proposals will receive funding. Grant funding will be provided directly from Pfizer.

Additional information can be found here.

Funding Sources

International Society of Amyloidosis
Pfizer Inc

This opportunity was posted by: RGCS

Last modified: June 29, 2021